Concepedia

Oral Fenretinide in Biochemically Recurrent Prostate Cancer: A California Cancer Consortium Phase II Trial

Eric Cheung, Jacek Pinski, Tanya B. Dorff, Susan Groshen, David I. Quinn, C. Patrick Reynolds, Barry J. Maurer, Primo N. Lara, Denice Tsao‐Wei, Przemyslaw Twardowski,

Clinical Genitourinary Cancer · 2009 · 31 citations · 59 references

DOI

Concepts

References

59

Cancer Statistics, 2007

Ahmedin Jemal, Rebecca L. Siegel, Elizabeth Ward et al. · CA A Cancer Journal for Clinicians · 2007 · 7.5K citations · Full text

, , +16

Optimal two-stage designs for phase II clinical trials

Richard Simon · Controlled Clinical Trials · 1989 · 3.6K citations

, , +10

Natural History of Progression After PSA Elevation Following Radical Prostatectomy

Charles R. Pound · JAMA · 1999 · 3.1K citations

, , +7

Eligibility and Response Guidelines for Phase II Clinical Trials in Androgen-Independent Prostate Cancer: Recommendations From the Prostate-Specific Antigen Working Group

Glenn J. Bubley, Michael A. Carducci, William L. Dahut et al. · Journal of Clinical Oncology · 1999 · 984 citations

, , +16

Randomized Trial of Fenretinide to Prevent Second Breast Malignancy in Women With Early Breast Cancer

Umberto Veronesi, G. De Palo, Ettore Marubini et al. · JNCI Journal of the National Cancer Institute · 1999 · 421 citations · Full text

, , +13